Mednet Logo
HomeHospital Medicine
Hospital Medicine

Hospital Medicine

Physician discussions on inpatient care, transitions of care, diagnostic reasoning, and hospital-based protocols.

Recent Discussions

Would you recommend genetic polymorphic testing before the initiation of antiplatelet medication in patients with ICAD?

2
4 Answers

Mednet Member
Mednet Member
Neurology · Brown University Medical School

This is not a bad idea if a rapid test is available. If the patient has clopidogrel resistance, I would treat it with brilinta.

Is concomitant use of azathioprine and febuxostat safe from a bone marrow toxicity standpoint?

4 Answers

Mednet Member
Mednet Member
Rheumatology · Ohio State University

No- Logan et al., PMID 31885095.See evidence. If you must use both for outside reasons- start really low and slow and monitor very very closely!

How do you manage a patient with progressive cerebellar ataxia and positive cardiolipin antibodies?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Hackensack University Medical Center

I would be very cautious attributing ataxia to the presence of ACL (even if they were persistent). While an association between ataxia and apl has been described, the differential is extremely broad and should be carefully worked up in conjunction with a neurology team. Some of the more common cause...

What is your approach to pulmonary vasodilator therapy in patients with COPD and Severe Group 3 Pulmonary Hypertension?

2
1 Answers

Mednet Member
Mednet Member
Pulmonology · Hospital of the University of Pennsylvania

I'd like to first acknowledge that there are no large randomized controlled trials specifically in patients with severe COPD-PH to guide practice. Before I consider PH-specific treatment, I like to exclude other causes of PH namely CTEPH, LHD, and CTD-PH which would influence treatment options. Seco...

Would you consider a primary prevention ICD in a patient with hypertrophic cardiomyopathy and non-sustained ventricular tachycardia, in the absence of any other high risk predictors for sudden cardiac death?

3
2 Answers

Mednet Member
Mednet Member
Cardiology · Baylor College of Medicine/ Texas Children's Hospital

Nonsustained ventricular tachycardia in hypertrophic cardiomyopathy without major risk factors (IIa primary prevention risk factors in 2020 ACC AHA HCM guidelines – max wall thickness >3 cm, FH SCD, LVEF <50%, unexplained syncope, LV apical aneurysm) remains a minor risk factor in adults (IIb consid...

When would you consider tapering glucocorticoids in a patient with ICI-associated myocarditis?

2 Answers

Mednet Member
Mednet Member
Cardiology · Memorial Sloan Kettering Cancer Center

Once troponins start to decrease, I start the steroid taper and follow troponin levels. If they rise, I slow the taper. I also get serial ECGs, esp if there were arrhythmia manifestations of myocarditis. Don't forget to assess for the need for PJP prophylaxis with Bactrim or pentamidine and PPI sinc...

What is your approach to rectal cancer staging in patients who cannot undergo an MRI?

1 Answers

Mednet Member
Mednet Member
Medical Oncology · Ohio State University Wexner Medical Center

Endoscopic ultrasound of the rectum in addition to CT scans with contrast, if any doubt, will do a PET/CT scan.

Do you typically get muscle MRI in patients with symptoms of myopathy?

2
1 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

Not routinely, but there are some scenarios where MRI is useful. Selection of muscle to biopsy in a chronic progressive myopathy. In the past, we used to select muscles based on the degree of weakness on the MRC scale and the EMG findings. One would avoid muscles with MRC strength of 3/5 or less or...

How do you approach the diagnostic workup for patients with suspected Fabry's disease?

1 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

Quite simple- if you suspect the disease in a male, you can measure alpha galactosidase enzyme activity in blood; if normal the diagnosis is unlikely, if abnormal you can confirm with GLA gene sequencing. If you suspect the disease in a female (manifesting carrier), you should directly sequence GLA ...

How do you counsel patients about the malignancy risk associated with azathioprine?

1 Answers

Mednet Member
Mednet Member
Rheumatology · UTMB Health

Malignancy with the use of AZA (Imuran) was documented many decades ago in a renal transplant population, not in rheumatoid patients. Are they equivalent? Overall I consider Imuran a pretty safe DMARD. In fact, it can be used in pregnant patients with lupus, with mothers and babies doing just fine.